OR8K1: A Potential Drug Target for Anosmia and Cancer (G390157)

Target Name: OR8K1

NCBI ID: G390157

OR8K1

OR8K1: A Potential Drug Target for Anosmia and Cancer

OR8K1 (Olfactory receptor family 8 subfamily K member 1) is a G protein-coupled receptor that is expressed in the olfactory system of the human nose. It is involved in the sense of smell and is one of the six olfactory receptor genes (OR1 , OR2, OR3, OR4, OR5, and OR6) that have been identified in the human genome. OR8K1 is a member of the Olfactory receptor family 8, which is a subfamily of the G protein-coupled receptor family 7.

The Olfactory system is responsible for detecting and recognizing scents in the environment. The sense of smell is the ability to identify and interpret the scents that are around us. The Olfactory receptor family 8 is responsible for detecting the chemical components of scents, such as the pheromones that are emitted by flowers or animals. The OR8K1 gene is one of the six genes that encode for a member of the Olfactory receptor family 8.

OR8K1 is a transmembrane protein that is expressed in the olfactory system of the human nose. It is composed of an extracellular portion, a transmembrane region, and an intracellular portion. The extracellular portion of OR8K1 is involved in its ability to interact with other proteins in the olfactory system. The transmembrane region of OR8K1 is responsible for its ligand binding and signal transduction. The intracellular portion of OR8K1 contains the catalytic activity of the receptor, which is responsible for the final step in the signal transduction cascade.

OR8K1 is involved in the sense of smell because it is a critical protein that is involved in the detection and recognition of scents in the environment. The Olfactory system is responsible for detecting the chemical components of scents and OR8K1 is responsible for detecting the pheromones that are emitted by flowers or animals. The sense of smell is the ability to identify and interpret the scents that are around us. The Olfactory receptor family 8 is responsible for detecting the chemical components of scents, such as the pheromones that are emitted by flowers or animals . The OR8K1 gene is one of the six genes that encode for a member of the Olfactory receptor family 8.

OR8K1 is a potential drug target because it is involved in the sense of smell. The development of new treatments for anosmia is an important area of 鈥嬧?媟esearch. Olfactory receptor family 8 subfamily K member 1 is a potential drug target because it is involved in the sense of smell. The development of new treatments for anosmia is an important area of 鈥嬧?媟esearch.

In addition to its involvement in the sense of smell, OR8K1 may also be a biomarker for certain diseases. For example, it is possible that OR8K1 may be involved in the development of certain cancers, such as breast cancer. Further research is needed to determine the role of OR8K1 in cancer progression.

Overall, OR8K1 is a G protein-coupled receptor that is involved in the sense of smell. It is a critical protein that is involved in the detection and recognition of scents in the environment. Further research is needed to determine the role of OR8K1 in drug development and as a biomarker for certain diseases.

Protein Name: Olfactory Receptor Family 8 Subfamily K Member 1

Functions: Odorant receptor

The "OR8K1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR8K1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets